Status:

UNKNOWN

Patency-Coronary Trial

Lead Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborating Sponsors:

Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Conditions:

Complications Due to Coronary Artery Bypass Graft

Graft Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Heart bypass surgery is used to increase blood flow to the heart. This surgery is usually done using a heart-lung machine (on-pump surgery) allowing the surgeon to perform the procedure on a still hea...

Detailed Description

Background: As Coronary Artery Bypass Grafting (CABG) aims to restore adequate blood supply to the ischemic heart, the success of the operation should depend mainly on the patency of the bypass grafts...

Eligibility Criteria

Inclusion

  • •All CORONARY (NCT00463294) patients reaching their one-year follow-up (9-24 months) will be included consecutively in the PATENCY-CORONARY trial.

Exclusion

  • Has a history of severe hypersensitivity to iodinated contrast agents;
  • Has known or suspected for pheochromocytoma;
  • Has severe renal impairment (estimated glomerular filtration rate, eGFR \<35 mL/min/1.73 m2). Patients with eGFR 35-50 mL/min/1.73 m2 will be treated with hydratation and N-acetylcysteine (Mucomyst®) as per local protocol for contrast administration;
  • Has rapid atrial fibrillation or any other cardiac rhythm that precludes reliable ECG triggering;
  • Has severe congestive heart failure, New York Heart Association (NYHA) Class IV;
  • Is a pregnant or lactating female.

Key Trial Info

Start Date :

August 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2015

Estimated Enrollment :

1200 Patients enrolled

Trial Details

Trial ID

NCT01414049

Start Date

August 1 2011

End Date

September 1 2015

Last Update

March 26 2014

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Libin Cardiovascular Institute of Alberta

Calgary, Alberta, Canada, T2N 2T9

2

Population Health Research Institute

Hamilton, Ontario, Canada, L8L2X2

3

Centre Hospitalier University de Montreal

Montreal, Quebec, Canada, H2W1T8

Patency-Coronary Trial | DecenTrialz